An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
KORU Medical Systems (NASDAQ: KRMD) announced it will report its fourth quarter and full year 2022 financial results on March 8, 2023, at 4:30 p.m. ET. A conference call and webcast will follow to discuss the results and provide a corporate update. The company's product line includes the FREEDOM Syringe Infusion System, which supports patient home care with innovative drug delivery solutions. Investors can access the call by dialing the provided numbers for the U.S., Canada, and international callers, or via the archived webcast on the company’s website.
Positive
Announcement of financial results to be reported on March 8, 2023.
Conference call provides opportunity for investor engagement and updates.
Negative
None.
MAHWAH, N.J.--(BUSINESS WIRE)--
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients, today announced that the Company will report fourth quarter and full year 2022 financial results on Wednesday, March 8, 2023. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international callers, using conference ID: 13736062. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
When will KORU Medical report its Q4 and full-year 2022 financial results?
KORU Medical will report its financial results on March 8, 2023.
What time is the KORU Medical conference call?
The conference call is scheduled for 4:30 p.m. ET on March 8, 2023.
How can I access the KORU Medical conference call?
You can access the conference call by dialing (877)-407-0784 for U.S. participants or (201)-689-8560 for international callers, using conference ID: 13736062.
Where can I find the archived webcast of KORU Medical's conference call?
The archived webcast will be available on KORU Medical's website under the investors section.
What products does KORU Medical offer?
KORU Medical develops subcutaneous drug delivery systems, including the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers.
